These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 407597)

  • 21. Changes in striatal dopamine metabolism during precipitated morphine withdrawal.
    Gramsch C; Bläsig J; Herz A
    Eur J Pharmacol; 1977 Aug; 44(3):231-40. PubMed ID: 560969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of type A and B monoamine oxidase on the formation of 3,4-dihydroxyphenylacetic acid (DOPAC) in tissues from the brain of the rat.
    Garrett MC; Soares-da-Silva P
    Neuropharmacology; 1990 Oct; 29(10):875-9. PubMed ID: 2123970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y; Komori T; Okuda S; Segawa T
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haloperidol inhibits the disappearance of acidic dopamine metabolites from rat striatum.
    Moleman P; Bruinvels J; van Valkenburg CF
    J Pharm Pharmacol; 1978 Sep; 30(9):583-5. PubMed ID: 29101
    [No Abstract]   [Full Text] [Related]  

  • 25. BIA 3-202, a novel catechol-O-methyltransferase inhibitor, enhances the availability of L-DOPA to the brain and reduces its O-methylation.
    Parada A; Loureiro AI; Vieira-Coelho MA; Hainzl D; Soares-da-Silva P
    Eur J Pharmacol; 2001 May; 420(1):27-32. PubMed ID: 11412836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
    Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
    J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of low-dose 4-fluorotranylcypromine on rat brain monoamine oxidase and neurotransmitter amines.
    Sherry RL; Baker GB; Coutts RT
    Biol Psychiatry; 1990 Sep; 28(6):539-43. PubMed ID: 1699613
    [No Abstract]   [Full Text] [Related]  

  • 28. Post-mortem degradation kinetics of brain norepinephrine.
    Faiman MD; Myers MB; Schowen RL
    Biochem Pharmacol; 1973 Sep; 22(17):2171-81. PubMed ID: 4733671
    [No Abstract]   [Full Text] [Related]  

  • 29. Dopaminergic responses to striatal damage.
    Howells DW; Liberatore GT; Wong JY; Donnan GA
    J Neurol Sci; 1996 Jul; 139(1):125-30. PubMed ID: 8836983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concentration of striatal tyramine and dopamine metabolism in diabetic rats and effect of insulin administration.
    Kwok RP; Juorio AV
    Neuroendocrinology; 1986; 43(5):590-6. PubMed ID: 3528901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholecystokinin attenuates basal and drug-induced increases of limbic and striatal dopamine release.
    Altar CA; Boyar WC; Oei E; Wood PL
    Brain Res; 1988 Sep; 460(1):76-82. PubMed ID: 3219572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
    Ilani T; Lamensdorf I; Finberg JP
    Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3-Methoxytyramine and different neuroleptics: dissociation from HVA and DOPAC.
    Groppetti A; Parenti M; Galli CL; Bugatti A; Cattabeni F; Di Giulio AM; Racagni G
    Life Sci; 1978 Oct; 23(17-18):1763-8. PubMed ID: 31531
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of apomorphine on in vivo release of dopamine and its metabolites in the prefrontal cortex and the striatum, studied by a microdialysis method.
    Ozaki N; Nakahara D; Miura H; Kasahara Y; Nagatsu T
    J Neurochem; 1989 Dec; 53(6):1861-4. PubMed ID: 2809596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cobalt injections into the substantia nigra of the rat: effects on behavior and dopamine metabolism in the striatum.
    Shibuya M; Fariello R; Farley IJ; Price KS; Lloyd KG; Hornykiewicz O
    Exp Neurol; 1978 Feb; 58(3):486-99. PubMed ID: 620704
    [No Abstract]   [Full Text] [Related]  

  • 36. Release of dopamine from central noradrenaline nerves after treatment with reserpine plus amphetamine.
    Andén NE; Svensson TH
    J Neural Transm; 1973; 34(1):23-30. PubMed ID: 4714591
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of halothane anaesthesia on extracellular levels of dopamine, dihydroxyphenylacetic acid, homovanillic acid and 5-hydroxyindolacetic acid in rat striatum: a microdialysis study.
    Ståhle L; Collin AK; Ungerstedt U
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):136-40. PubMed ID: 1700307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spontaneous and drug-induced changes of cerebral dopamine turnover during postnatal development of rats.
    Keller HH; Bartholini G; Pletscher A
    Brain Res; 1973 Dec; 64():371-8. PubMed ID: 4781347
    [No Abstract]   [Full Text] [Related]  

  • 39. Measurement of 3,4-dihydroxyphenylacetic acid and 3-methoxytyramine specific activity rat striatum.
    Di Giulio AM; Groppetti A; Algeri S; Ponzio F; Cattabeni F; Galli CL
    Anal Biochem; 1979 Jan; 92(1):82-90. PubMed ID: 426290
    [No Abstract]   [Full Text] [Related]  

  • 40. Significance of dopamine metabolites in the evaluation of drugs acting on dopaminergic neurons.
    Di Giulio AM; Groppetti A; Cattabeni F; Galli CL; Maggi A; Algeri S; Ponzio F
    Eur J Pharmacol; 1978 Nov; 52(2):201-7. PubMed ID: 729633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.